NYSE:GMREGlobal Medical REIT Stock Price, Forecast & News

$11.25

+0.02 (+0.18 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$11.13

Now: $11.25▼

$11.51

50-Day Range

$8.90

MA: $10.62▼

$11.68

52-Week Range

$6.98

Now: $11.25▼

$15.95

Volume342,900 shs

Average Volume459,331 shs

Market Capitalization$506.40 million

P/E Ratio102.28

Dividend Yield7.11%

Beta0.74

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Global Medical REIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $15.10, Global Medical REIT has a potential upside of 34.2% from its current price of $11.25.
Amount of Analyst Coverage
Global Medical REIT has only been the subject of 3 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
Global Medical REIT has received 267 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Global Medical REIT has received 256 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Global Medical REIT has received 51.05% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote “Outperform” if you believe GMRE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
Global Medical REIT is a leading dividend payer. It pays a dividend yield of 7.11%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Global Medical REIT has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of Global Medical REIT is 106.67 %. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 86.02 % in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.

4.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Global Medical REIT insiders have bought more of their company's stock than they have sold. Specifically, they have bought $19,982.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 11.70% of the stock of Global Medical REIT is held by insiders.
Percentage Held by Institutions
59.77% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Global Medical REIT are expected to grow by 12.05% in the coming year, from $0.83 to $0.93 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Global Medical REIT is 102.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of Global Medical REIT is 102.28, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.16.
Price to Book Value per Share Ratio
Global Medical REIT has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.48 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Real estate investment trusts

Sub-IndustryN/A

SectorFinance

Current SymbolNYSE:GMRE

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.globalmedicalreit.com

Phone202-524-6851

Debt

Debt-to-Equity Ratio1.19

Current Ratio0.37

Quick Ratio0.37

Price-To-Earnings

Trailing P/E Ratio102.28

Forward P/E Ratio13.55

P/E GrowthN/A

Sales & Book Value

Annual Sales$70.73 million

Price / Sales7.16

Cash Flow$0.82 per share

Price / Cash Flow13.69

Book Value$8.08 per share

Price / Book1.39

Profitability

EPS (Most Recent Fiscal Year)$0.75

Net Income$9.23 million

Net Margins11.13%

Return on Equity2.58%

Return on Assets1.01%

Miscellaneous

EmployeesN/A

Outstanding Shares45,013,000

Market Cap$506.40 million

Next Earnings Date8/5/2020 (Estimated)

OptionableOptionable

Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.

Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

How has Global Medical REIT's stock been impacted by COVID-19 (Coronavirus)?

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GMRE stock has decreased by 9.3% and is now trading at $11.25. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Global Medical REIT?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Global Medical REIT.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Global Medical REIT.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc (NYSE:GMRE) announced its earnings results on Wednesday, May, 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.20 by $0.17. The company earned $21.65 million during the quarter, compared to the consensus estimate of $21.04 million. Global Medical REIT had a net margin of 11.13% and a return on equity of 2.58%. View Global Medical REIT's earnings history.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Tuesday, March 3rd. Shareholders of record on Wednesday, March 25th will be given a dividend of $0.20 per share on Thursday, April 9th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 7.11%. The ex-dividend date is Tuesday, March 24th. View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

5 Wall Street analysts have issued 12-month target prices for Global Medical REIT's shares. Their forecasts range from $12.00 to $17.00. On average, they anticipate Global Medical REIT's share price to reach $15.10 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price. View analysts' price targets for Global Medical REIT.

Has Global Medical REIT been receiving favorable news coverage?

Media coverage about GMRE stock has trended extremely negative on Friday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Global Medical REIT earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutGlobal Medical REIT.

Who are some of Global Medical REIT's key competitors?

Some companies that are related to Global Medical REIT include Caretrust REIT (CTRE), Easterly Government Properties (DEA), Paramount Group (PGRE), Washington Real Estate Investment Trust (WRE), RLJ Lodging Trust (RLJ), Safestore (SFSHF), Brandywine Realty Trust (BDN), CHIMERA INVT CO/SH NEW (CIM), Four Corners Property Trust (FCPT), American Assets Trust (AAT), Columbia Property Trust (CXP), Uniti Group (UNIT), LTC Properties (LTC), The GEO Group (GEO) and Corecivic (CXW). View all competitors.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), Square (SQ), Big Lots (BIG), New Residential Investment (NRZ), Ready Capital (RC), AGNC Investment (AGNC), AT&T (T) and Energy Transfer LP Unit (ET).

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the following people:

Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
Danica Holley, Chief Operating Officer
Robert J. Kiernan, Chief Financial Officer & Treasurer
Alfonzo Leon, Chief Investment Officer
Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.72%), State Street Corp (2.09%), Wells Fargo & Company MN (1.91%), Geode Capital Management LLC (1.29%), Invesco Ltd. (1.18%) and JPMorgan Chase & Co. (0.89%). Company insiders that own Global Medical REIT stock include Henry Cole, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View institutional ownership trends for Global Medical REIT.

Which major investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Two Sigma Investments LP, Foundry Partners LLC, Nuveen Asset Management LLC, ClariVest Asset Management LLC, UBS Group AG, Chicago Equity Partners LLC, and WINTON GROUP Ltd. View insider buying and selling activity for Global Medical REIT.

Which major investors are buying Global Medical REIT stock?

GMRE stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Crown Advisors Management Inc., JPMorgan Chase & Co., Virtus ETF Advisers LLC, Geode Capital Management LLC, Wells Fargo & Company MN, and Wedge Capital Management L L P NC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Ronald Marston, and Zh Usa, Llc. View insider buying and selling activity for Global Medical REIT.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $11.25.

How big of a company is Global Medical REIT?

Global Medical REIT has a market capitalization of $506.40 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.

This page was last updated on 5/29/2020 by MarketBeat.com Staff